Programmable and selective silencing of oncogenic fusion transcripts by CRISPR-Cas13b via breakpoint sequence recognition
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Here, we establish CRISPR- Psp Cas13b as a personalizable platform for systematic silencing of various fusion transcripts.
Appeared: Sunday, October 18. Science Advances. Peer-reviewed journal.